{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:45:39Z","timestamp":1761237939331,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1378\/chest.12-0848","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T11:21:11Z","timestamp":1349176871000},"page":"816-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["F2-Isoprostanes"],"prefix":"10.1016","volume":"142","author":[{"given":"Peter","family":"Dromparis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos D.","family":"Michelakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1378\/chest.12-0848_bib1","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.12-0848_bib2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1378\/chest.11-1267","article-title":"Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension","volume":"142","author":"Cracowski","year":"2012","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.12-0848_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/ajrccm.164.6.2104033","article-title":"Increased lipid peroxidation in patients with pulmonary hypertension","volume":"164","author":"Cracowski","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.12-0848_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/2045-8932.78107","article-title":"Oxidative injury is a common consequence of BMPR2 mutations","volume":"1","author":"Lane","year":"2011","journal-title":"Pulm Circ"},{"issue":"10","key":"10.1378\/chest.12-0848_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s11745-005-1460-7","article-title":"Recent advances in the biochemistry and clinical relevance of the isoprostane pathway","volume":"40","author":"Musiek","year":"2005","journal-title":"Lipids"},{"issue":"4","key":"10.1378\/chest.12-0848_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1165\/rcmb.2008-0109TR","article-title":"Isoprostanes and lung vascular pathology","volume":"39","author":"Janssen","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1378\/chest.12-0848_bib7","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1378\/chest.09-2815","article-title":"Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension","volume":"138","author":"Rich","year":"2010","journal-title":"Chest"},{"issue":"8","key":"10.1378\/chest.12-0848_bib8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/ars.2007.1956","article-title":"F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications","volume":"10","author":"Basu","year":"2008","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"10.1378\/chest.12-0848_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00109-011-0762-2","article-title":"Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNF\u03b1 contributes to the pathogenesis of pulmonary arterial hypertension","volume":"89","author":"Sutendra","year":"2011","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"10.1378\/chest.12-0848_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1183\/09031936.00000508","article-title":"Insulin resistance in pulmonary arterial hypertension","volume":"33","author":"Zamanian","year":"2009","journal-title":"Eur Respir J"},{"issue":"44","key":"10.1378\/chest.12-0848_bib11","doi-asserted-by":"crossref","first-page":"44ra58","DOI":"10.1126\/scitranslmed.3001327","article-title":"Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension","volume":"2","author":"Sutendra","year":"2010","journal-title":"Sci Transl Med"},{"issue":"88","key":"10.1378\/chest.12-0848_bib12","doi-asserted-by":"crossref","first-page":"88ra55","DOI":"10.1126\/scitranslmed.3002194","article-title":"The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension","volume":"3","author":"Sutendra","year":"2011","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1378\/chest.12-0848_bib13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1073\/pnas.0605080104","article-title":"Alterations of cellular bioenergetics in pulmonary artery endothelial cells","volume":"104","author":"Xu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"10.1378\/chest.12-0848_bib14","doi-asserted-by":"crossref","first-page":"31ra34","DOI":"10.1126\/scitranslmed.3000677","article-title":"Metabolic modulation of glioblastoma with dichloroacetate","volume":"2","author":"Michelakis","year":"2010","journal-title":"Sci Transl Med"},{"issue":"7113","key":"10.1378\/chest.12-0848_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"7329","key":"10.1378\/chest.12-0848_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1378\/chest.12-0848_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0014-5793(98)00481-5","article-title":"Metabolism of 8-iso-prostaglandin F2alpha","volume":"428","author":"Basu","year":"1998","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1378\/chest.12-0848_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0006-2952(02)01607-6","article-title":"Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes","volume":"65","author":"Montine","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1378\/chest.12-0848_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/abbi.1998.0645","article-title":"Comparison of formation of D2\/E2-isoprostanes and F2-isoprostanes in vitro and in vivo\u2014effects of oxygen tension and glutathione","volume":"353","author":"Morrow","year":"1998","journal-title":"Arch Biochem Biophys"},{"issue":"20","key":"10.1378\/chest.12-0848_bib20","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/hmg\/ddn214","article-title":"Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue","volume":"17","author":"Sobolewski","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1378\/chest.12-0848_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ahj.2009.11.028","article-title":"Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed","volume":"159","author":"Macchia","year":"2010","journal-title":"Am Heart J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212605443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212605443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:33:01Z","timestamp":1757917981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212605443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0012369212605443"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-0848","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"F2-Isoprostanes","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-0848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}